So many people die in the region because they do not get essential medicines. Studies show that only 20 percent of drugs are distributed through government-run institutions like hospitals in the region. The public health delivery systems are so weak in South Asia that 80 percent of drugs are purchased directly by people. The industry's claim that it will protect the public health concerns is questionable. Neither would the new trade regime take into account the diverse socio-economic situations in the developing countries.
All countries are at different stages of development.
But the overwhelming opinion, as put forward by Dr Bala, was that developing countries can have better access only when chemical intermediates, raw materials and finished products are available at competitive prices in the world market.